Statin Therapy Is Associated with Decreased Small, Dense Low-Density Lipoprotein Levels in Patients Undergoing Peritoneal Dialysis

作者: Anna Clementi , Jeong Chul Kim , Matteo Floris , Dinna N. Cruz , Francesco Garzotto

DOI: 10.1159/000337829

关键词:

摘要: Cardiovascular disease is a major cause of morbidity and mortality among hemodialysis (HD) peritoneal dialysis (PD) patients, dyslipidemia plays an important role in its pathogenesis. In particular, small, dense LDL (sd-LDL) particles have been recently highlighted as emerging cardiovascular risk factor. PD patients exhibit more overtly abnormal lipid profile than HD probably due to the metabolic interference fluid. Statins are main drugs for treatment they able decrease all subclasses levels, but it remains unclear whether can influence proportion sd-LDL. Only few studies regarding effect statins on these performed and, our knowledge, no trials carried out patients. Therefore, we compared sd-LDL two populations Our study suggests that statin therapy may be effective reducing both absolute amount with profile, such undergoing dialysis. do not seem altering levels other factors subtractions generation, hypertension diabetes mellitus. If when results prove reproducible large-scale studies, should provide new insights into actual atherogenesis or

参考文章(10)
Hong Euy Lim, Un Jung Choi, Hong Seog Seo, Dong Joo Oh, Jin Won Kim, Jin Oh Na, Chang Gyu Park, Cheol Ung Choi, Seung Yong Shin, Eung Ju Kim, Seung Woon Rha, Eun Mi Lee, Statins Do Not Decrease Small, Dense Low-Density Lipoprotein Texas Heart Institute Journal. ,vol. 37, pp. 421- 428 ,(2010)
RL Lins, KE Matthys, Jean Marie Billiouw, Max Dratwa, Pierre Dupont, NH Lameire, PC Peeters, Jean Claude Stolear, Christian Tielemans, Björn Maes, GA Verpooten, Jean Ducobu, YA Carpentier, Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study. Clinical Nephrology. ,vol. 62, pp. 287- 294 ,(2004) , 10.5414/CNP62287
G Franceschini, M Cassinotti, G Vecchio, G Gianfranceschi, F Pazzucconi, T Murakami, M Sirtori, A L D'Acquarica, C R Sirtori, PRAVASTATIN EFFECTIVELY LOWERS LDL CHOLESTEROL IN FAMILIAL COMBINED HYPERLIPIDEMIA WITHOUT CHANGING LDL SUBCLASS PATTERN Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 14, pp. 1569- 1575 ,(1994) , 10.1161/01.ATV.14.10.1569
Florian Kronenberg, Arno Lingenhel, Ulrich Neyer, Karl Lhotta, Paul König, Martin Auinger, Martin Wiesholzer, Helene Andersson, Hans Dieplinger, Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients Kidney International. ,vol. 63, pp. S113- S116 ,(2003) , 10.1046/J.1523-1755.63.S84.23.X
Tetsuo Shoji, Yoshiki Nishizawa, Hiroshi Nishitani, Makoto Yamakawa, Hirotoshi Morii, Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis Metabolism. ,vol. 40, pp. 1002- 1008 ,(1991) , 10.1016/0026-0495(91)90120-L
Sohvi Hörkkö, Kaisa Huttunen, Esa Läärä, Kari Kervinen, Y. Antero Kesäniemi, Effects of three treatment modes on plasma lipids and lipoproteins in uraemic patients. Annals of Medicine. ,vol. 26, pp. 271- 282 ,(1994) , 10.3109/07853899409147902
Sebastian J.H. Bredie, Frank H. Bosch, Pierre N.M. Demacker, Anton F.H. Stalenhoef, Robert Van Leusen, Effects of Peritoneal Dialysis with an Overnight Icodextrin Dwell on Parameters of Glucose and LIPID Metabolism Peritoneal Dialysis International. ,vol. 21, pp. 275- 281 ,(2001) , 10.1177/089686080102100308
M. Rizzo, K. Berneis, G. A. Spinas, G. B. Rini, N. K. Kapur, Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance? International Journal of Clinical Practice. ,vol. 63, pp. 478- 485 ,(2009) , 10.1111/J.1742-1241.2008.01979.X
Colin Baigent, Martin J Landray, Christina Reith, Jonathan Emberson, David C Wheeler, Charles Tomson, Christoph Wanner, Vera Krane, Alan Cass, Jonathan Craig, Bruce Neal, Lixin Jiang, Lai Seong Hooi, Adeera Levin, Lawrence Agodoa, Mike Gaziano, Bertram Kasiske, Robert Walker, Ziad A Massy, Bo Feldt-Rasmussen, Udom Krairittichai, Vuddidhej Ophascharoensuk, Bengt Fellström, Hallvard Holdaas, Vladimir Tesar, Andrzej Wiecek, Diederick Grobbee, Dick De Zeeuw, Carola Grönhagen-Riska, Tanaji Dasgupta, David Lewis, William Herrington, Marion Mafham, William Majoni, Karl Wallendszus, Richard Grimm, Terje Pedersen, Jonathan Tobert, Jane Armitage, Alex Baxter, Christopher Bray, Yiping Chen, Zhengming Chen, Michael Hill, Carol Knott, Sarah Parish, David Simpson, Peter Sleight, Alan Young, Rory Collins, None, The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial The Lancet. ,vol. 377, pp. 2181- 2192 ,(2011) , 10.1016/S0140-6736(11)60739-3
A.F.H. Stalenhoef, S.H.A. Diepeveen, S.J.H. Bredie, R. van Leusen, J.M. van den Akker, L.J.H. van Tits, Atorvastatin and simvastatin in patients on hemodialysis: effects on lipoproteins, C-reactive protein and in vivo oxidized LDL. Journal of Nephrology. ,vol. 16, pp. 238- 244 ,(2003)